Meaning-Centered Psychotherapy Training for Cancer Care Providers
NCT ID: NCT02730039
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
350 participants
OBSERVATIONAL
2015-12-11
2026-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer Care Providers
Provider will attend a MCPT two-day intensive workshop that will include:
* Didactic Components
* Experiential Exercises
* Simulated patient role plays with actors
* Provider completes MCPT Workshop Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL)
* MCP Core Competency Trainer rated Assessment
* MCP Pre \& Post Workshop Knowledge Assessment
* MCPT Session Evaluation Assessment Provider will participate in training follow-up calls \& webinars for approximately 6 -12 months following completion of MCPT workshop.
* Provider will have ongoing access to MCPT Website with a discussion board, training resources and materials for clinical care.
* Provider will complete follow-up assessment at 3, 6, 9, \& 12 months post-training
* Training Update
* Goal Evaluation Form
* MCP Core Competency Self-Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL)
workshop
follow-up calls & webinars
assessments
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
workshop
follow-up calls & webinars
assessments
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed online MCPT application form and commits to attend the two-day intensive MCPT program, complete training follow-up assessments, and participate in required follow-up training activities.
* Able to speak, read, and understand English proficiently to participate in MCPT training sessions and complete assessments.
Exclusion Criteria
* Materials for the training and the training will be conducted in English only.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Northwestern University
OTHER
MJHS Institute for Innovation in Palliative Care
OTHER
Massachusetts General Hospital
OTHER
City of Hope Medical Center
OTHER
Dana-Farber Cancer Institute
OTHER
New York Presbyterian Hospital
OTHER
Odette Cancer Center - Sunnybrook Hospital
UNKNOWN
VA New York Harbor Healthcare System
FED
University of Pennsylvania
OTHER
Smilow Cancer Hospital - Yale New Haven Health
UNKNOWN
Department of Veterans Affairs, New Jersey
FED
Vidant Cancer Care
UNKNOWN
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Breitbart, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-321
Identifier Type: -
Identifier Source: org_study_id